Halozyme Therapeutics shares owned by Meritage Portfolio Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Meritage Portfolio Management
from 13F filings
Historical chart of Meritage Portfolio Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Meritage Portfolio Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Meritage Portfolio Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.6M | 90k | 73.34 |
| 2025-06-30 | $5.3M | 102k | 52.02 |
| 2025-03-31 | $6.5M | 102k | 63.81 |
| 2022-12-31 | $11M | 198k | 56.90 |
| 2022-09-30 | $8.1M | 205k | 39.54 |
More positions owned by Meritage Portfolio Management
View all positions for Meritage Portfolio Management